by pbn | Dec 1, 2022 | Press Releases
We are so happy that WAPO published an article about the extremely interesting work being carried out by Dr Dina Dechmann, Dr Liliana Dávalos, and 2N Pharma CSO and Aalborg University associate prof. Dr John Dirk Vestergaard Nieland. In the winter, the...
by pbn | Jun 23, 2021 | Press Releases
Aalborg, Denmark, 23 June 2021 – 2N Pharma, a biotech company developing therapeutic drugs to treat neurological disorders, today announced the appointment of Alex Leech as Chair of the Board of Directors and John Kemp as Non-Executive Director. “We are...
by pbn | Jun 23, 2021 | Board of Directors
Alex Leech was the founding CEO of Alchemab Therapeutics and raised a £60m ($82m) Series A in 2021. He is a serial biotech CEO having led Creabilis, a leading European dermatology company, until its acquisition by Sienna Biopharmaceuticals Inc. in December 2016 and...
by pbn | Jun 23, 2021 | Board of Directors
John Kemp is currently the CSO of Syndesi Therapeutics. Former roles include Head of Neuroscience Discovery at Janssen, Belgium, and CEO of Evotec Neurosciences, which was spun-out from Evotec and raised a €25m Series A in 2004. Before joining Evotec, John was SVP and...
by pbn | Jun 23, 2021 | Board of Directors
John is 2N Pharma’s co-founder and CSO and brings broad management experience and in-depth research background. He was previously director of research at Medigene AG and is co-founder of the clinical-stage vaccine company 2A Pharma and two other biotech...
Recent Comments